Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Williams

Showing results (281-290 of 417) with videos related to

Pageof 42
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 30, 2008
Cardiovascular protection for all individuals at high risk: evidence-based best practiceGeorge Bakris, Michael Böhm, Gilles Dagenais, et al.
American Journal of Hypertension|January 23, 2019
Schedules for Self-monitoring Blood Pressure: A Systematic ReviewJames A Hodgkinson, Richard Stevens, Sabrina Grant, et al.
Journal of Hypertension|June 30, 2021
Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or strokeMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
European Heart Journal|December 28, 2018
Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Heart (British Cardiac Society)|November 29, 2014
Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertensionMelvin D Lobo, Mark A de Belder, Trevor Cleveland, et al.
Lancet (London, England)|March 7, 2026
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trialMichel Azizi, Jenifer M Brown, Jamie P Dwyer, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2019
Emergence of Home Blood Pressure-Guided Management of Hypertension Based on Global EvidenceKazuomi Kario, Daichi Shimbo, Satoshi Hoshide, et al.
Hypertension (Dallas, Tex. : 1979)|November 5, 2021
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence TestingDan Lane, Alexander Lawson, Angela Burns, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 24, 2025
Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24John M Flack, Michel Azizi, Jenifer M Brown, et al.
JAMA|September 4, 2013
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trialStephen J Nicholls, George L Bakris, John J P Kastelein, et al.
Pageof 42

Showing results (281-290 of 417) with videos related to

Sort By:
Pageof 42
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 30, 2008
Cardiovascular protection for all individuals at high risk: evidence-based best practiceGeorge Bakris, Michael Böhm, Gilles Dagenais, et al.
American Journal of Hypertension|January 23, 2019
Schedules for Self-monitoring Blood Pressure: A Systematic ReviewJames A Hodgkinson, Richard Stevens, Sabrina Grant, et al.
Journal of Hypertension|June 30, 2021
Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or strokeMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
European Heart Journal|December 28, 2018
Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Heart (British Cardiac Society)|November 29, 2014
Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertensionMelvin D Lobo, Mark A de Belder, Trevor Cleveland, et al.
Lancet (London, England)|March 7, 2026
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trialMichel Azizi, Jenifer M Brown, Jamie P Dwyer, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2019
Emergence of Home Blood Pressure-Guided Management of Hypertension Based on Global EvidenceKazuomi Kario, Daichi Shimbo, Satoshi Hoshide, et al.
Hypertension (Dallas, Tex. : 1979)|November 5, 2021
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence TestingDan Lane, Alexander Lawson, Angela Burns, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 24, 2025
Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24John M Flack, Michel Azizi, Jenifer M Brown, et al.
JAMA|September 4, 2013
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trialStephen J Nicholls, George L Bakris, John J P Kastelein, et al.
Pageof 42